Autologous chondrocyte implantation (Ocugen)
N/A
Report date: 2022/12/27 09:23:12
Base Information
Drug NameAutologous chondrocyte implantation (Ocugen)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesHistogenics Co
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A